202 related articles for article (PubMed ID: 25852750)
1. The phenotypic expression of mitochondrial tRNA-mutations can be modulated by either mitochondrial leucyl-tRNA synthetase or the C-terminal domain thereof.
Giordano C; Morea V; Perli E; d'Amati G
Front Genet; 2015; 6():113. PubMed ID: 25852750
[TBL] [Abstract][Full Text] [Related]
2. The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells.
Perli E; Giordano C; Pisano A; Montanari A; Campese AF; Reyes A; Ghezzi D; Nasca A; Tuppen HA; Orlandi M; Di Micco P; Poser E; Taylor RW; Colotti G; Francisci S; Morea V; Frontali L; Zeviani M; d'Amati G
EMBO Mol Med; 2014 Feb; 6(2):169-82. PubMed ID: 24413190
[TBL] [Abstract][Full Text] [Related]
3. Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy.
Perli E; Giordano C; Tuppen HA; Montopoli M; Montanari A; Orlandi M; Pisano A; Catanzaro D; Caparrotta L; Musumeci B; Autore C; Morea V; Di Micco P; Campese AF; Leopizzi M; Gallo P; Francisci S; Frontali L; Taylor RW; d'Amati G
Hum Mol Genet; 2012 Jan; 21(1):85-100. PubMed ID: 21945886
[TBL] [Abstract][Full Text] [Related]
4. Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations.
Perli E; Fiorillo A; Giordano C; Pisano A; Montanari A; Grazioli P; Campese AF; Di Micco P; Tuppen HA; Genovese I; Poser E; Preziuso C; Taylor RW; Morea V; Colotti G; d'Amati G
Hum Mol Genet; 2016 Mar; 25(5):903-15. PubMed ID: 26721932
[TBL] [Abstract][Full Text] [Related]
5. The yeast model suggests the use of short peptides derived from mt LeuRS for the therapy of diseases due to mutations in several mt tRNAs.
Di Micco P; Fazzi D'Orsi M; Morea V; Frontali L; Francisci S; Montanari A
Biochim Biophys Acta; 2014 Dec; 1843(12):3065-74. PubMed ID: 25261707
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Ability of LARS2 Carboxy-Terminal Domain in Rescuing the MELAS Phenotype.
Capriglia F; Rizzo F; Petrosillo G; Morea V; d'Amati G; Cantatore P; Roberti M; Loguercio Polosa P; Bruni F
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357047
[TBL] [Abstract][Full Text] [Related]
7. Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations.
Hornig-Do HT; Montanari A; Rozanska A; Tuppen HA; Almalki AA; Abg-Kamaludin DP; Frontali L; Francisci S; Lightowlers RN; Chrzanowska-Lightowlers ZM
EMBO Mol Med; 2014 Feb; 6(2):183-93. PubMed ID: 24413189
[TBL] [Abstract][Full Text] [Related]
8. The C-terminal domain of the archaeal leucyl-tRNA synthetase prevents misediting of isoleucyl-tRNA(Ile).
Fukunaga R; Yokoyama S
Biochemistry; 2007 May; 46(17):4985-96. PubMed ID: 17407269
[TBL] [Abstract][Full Text] [Related]
9. Mixing and matching mitochondrial aminoacyl synthetases and their tRNAs: a new way to treat respiratory chain disorders?
Tyynismaa H; Schon EA
EMBO Mol Med; 2014 Feb; 6(2):155-7. PubMed ID: 24473201
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation.
Rorbach J; Yusoff AA; Tuppen H; Abg-Kamaludin DP; Chrzanowska-Lightowlers ZM; Taylor RW; Turnbull DM; McFarland R; Lightowlers RN
Nucleic Acids Res; 2008 May; 36(9):3065-74. PubMed ID: 18400783
[TBL] [Abstract][Full Text] [Related]
11. Recognition of human mitochondrial tRNALeu(UUR) by its cognate leucyl-tRNA synthetase.
Sohm B; Sissler M; Park H; King MP; Florentz C
J Mol Biol; 2004 May; 339(1):17-29. PubMed ID: 15123417
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.
Fine AS; Nemeth CL; Kaufman ML; Fatemi A
J Neurodev Disord; 2019 Dec; 11(1):29. PubMed ID: 31839000
[TBL] [Abstract][Full Text] [Related]
13. Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations.
González-Serrano LE; Karim L; Pierre F; Schwenzer H; Rötig A; Munnich A; Sissler M
J Biol Chem; 2018 Aug; 293(35):13604-13615. PubMed ID: 30006346
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial diseases: Yeast as a model for the study of suppressors.
Francisci S; Montanari A
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):666-673. PubMed ID: 28089773
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of human mitochondrial alanyl-tRNA synthetase suppresses biochemical defects of the mt-tRNA
Zhao X; Han J; Zhu L; Xiao Y; Wang C; Hong F; Jiang P; Guan MX
Int J Biol Sci; 2018; 14(11):1437-1444. PubMed ID: 30262995
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.
Park H; Davidson E; King MP
RNA; 2008 Nov; 14(11):2407-16. PubMed ID: 18796578
[TBL] [Abstract][Full Text] [Related]
17. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.
Li R; Guan MX
Mol Cell Biol; 2010 May; 30(9):2147-54. PubMed ID: 20194621
[TBL] [Abstract][Full Text] [Related]
18. Aminoacyl-tRNA synthetases are multivalent suppressors of defects due to human equivalent mutations in yeast mt tRNA genes.
Montanari A; De Luca C; Frontali L; Francisci S
Biochim Biophys Acta; 2010 Sep; 1803(9):1050-7. PubMed ID: 20471434
[TBL] [Abstract][Full Text] [Related]
19. Role of Mutations of Mitochondrial Aminoacyl-tRNA Synthetases Genes on Epileptogenesis.
Kong LY; Wu YZ; Cheng RQ; Wang PH; Peng BW
Mol Neurobiol; 2023 Sep; 60(9):5482-5492. PubMed ID: 37316759
[TBL] [Abstract][Full Text] [Related]
20. An aminoacyl-tRNA synthetase with a defunct editing site.
Lue SW; Kelley SO
Biochemistry; 2005 Mar; 44(8):3010-6. PubMed ID: 15723544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
